- Home
- FSS vs MIRM Comparison
FSS vs MIRM Comparison
Compare FSS & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FSS | MIRM |
|---|---|---|
| Founded | 1901 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 5.7B |
| IPO Year | 1994 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FSS | MIRM |
|---|---|---|
| Price | $112.55 | $94.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $131.75 | $119.85 |
| AVG Volume (30 Days) | 397.2K | ★ 916.0K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.46% | N/A |
| EPS Growth | 14.57 | ★ 74.59 |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $2,180,500,000.00 | $19,138,000.00 |
| Revenue This Year | $20.94 | $26.22 |
| Revenue Next Year | $6.79 | $22.04 |
| P/E Ratio | $97.61 | ★ N/A |
| Revenue Growth | ★ 17.14 | N/A |
| 52 Week Low | $91.48 | $42.89 |
| 52 Week High | $132.89 | $114.99 |
Technical Indicators
Market Signals| Indicator | FSS | MIRM |
|---|---|---|
| Relative Strength Index (RSI) | 44.92 | 43.82 |
| Support Level | $107.17 | $87.26 |
| Resistance Level | $115.93 | $98.03 |
| Average True Range (ATR) | 4.06 | 7.01 |
| MACD | -1.10 | -0.39 |
| Stochastic Oscillator | 17.62 | 27.63 |
Price Performance
Historical ComparisonAbout FSS Federal Signal Corporation
Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates through two segments. The Environmental Solutions Group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group manufactures and supplies comprehensive systems and products used by law enforcement, fire rescue, and industrial sites to protect people and property. Its offerings include systems for community alerting and industrial communications. The company generates the majority of its revenue from the Environmental Solutions Group segment.
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.